UK Royal Navy Type 23 frigate HMS Northumberland is to undergo a nine-month refit provided by Babcock at its Devonport Royal Dockyard facility to increase the frigate’s sustainability and fighting capability.

The upgrade contract was awarded under the Surface Ship Support Alliance – the alliance between the UK Ministry of Defence (MoD), Babcock and BAE Systems.

HMS Northumberland will receive 13 upgrades that include the new DNA (2) command system, installation of the defence information infrastructure (future) (DII(F)), the SeaWolf mid-life update (SWMLU) consisting of tracking, guidance and weapon management upgrades.

The upgrades also include installation of a new automatic small calibre gun (ASCG) and the replacement of nuclear, chemical and biological incident surveillance system (NBCDISS) with a new sophisticated, digital system.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The upgrades will be undertaken alongside a full programme of deep maintenance, including replacement of the Sonar 2050 dome and array, port and starboard shafts, and the port main propulsion gear wheel.

The frigate will rejoin the fleet on completion of sea trials in December 2011.